trial

Effectiveness of the RemedRugby Program

NCTId NCT03775564
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 60 (actual)
Sponsored by Hospital Center Alpes-Isère
Primary completion 2018-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
60 (actual)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2014-11
Primary completion
2018-03
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
REMEDRUGBY PROGRAMTOUCH RUGBY PROGRAMTAU

Sponsors

Hospital Center Alpes-IsèreLead Sponsor
Centre Hospitalier Le Valmont (Valence)Collaborator
Hôpital le VinatierCollaborator
Centre Hospitalier Spécialisé de la Savoie (Chambéry)Collaborator
Centre Hospitalier Annecy GenevoisCollaborator
Centre Hospitalier Universitaire de Saint EtienneCollaborator
Centre Hospitalier Sainte Marie de Clermont FerrandCollaborator
University Hospital, Clermont-FerrandCollaborator

Investigators

1
Julien JD DUBREUCQ, MDPrincipal Investigator

Sites

8 total
Annecy, FranceBron, FranceChambéry, FranceClermont-Ferrand, FranceClermont-Ferrand, FranceSaint-Etienne, FranceSaint-Égrève, FranceValence, France

Facts & assertions

4 sourced
Enrollment
60
Phase
NA
Primary Completion Date
2018-03
Status
COMPLETED
relationships
The graph out of here
drug
REMEDRUGBY PROGRAM
drug
TOUCH RUGBY PROGRAM
drug
TAU
drug
lead_sponsor
Hospital Center Alpes-Isère
company
collaborator
Centre Hospitalier Le Valmont (Valence)
company
Hôpital le Vinatier
company
indication
Empowerment
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Julien JD DUBREUCQ, MD
person